RU93058535A - TABLET CONTAINING KOLESTIPOL HYDROCHLORIDE AND METHOD FOR PRODUCING IT - Google Patents

TABLET CONTAINING KOLESTIPOL HYDROCHLORIDE AND METHOD FOR PRODUCING IT

Info

Publication number
RU93058535A
RU93058535A RU93058535/14A RU93058535A RU93058535A RU 93058535 A RU93058535 A RU 93058535A RU 93058535/14 A RU93058535/14 A RU 93058535/14A RU 93058535 A RU93058535 A RU 93058535A RU 93058535 A RU93058535 A RU 93058535A
Authority
RU
Russia
Prior art keywords
kolestipol
hydrochloride
producing
tablet containing
new
Prior art date
Application number
RU93058535/14A
Other languages
Russian (ru)
Other versions
RU2108090C1 (en
Inventor
Вью-вей Шен Роберт
Эллис Прайс Джеффри
Original Assignee
Дзе Апджон Компани
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Дзе Апджон Компани filed Critical Дзе Апджон Компани
Priority claimed from PCT/US1992/005066 external-priority patent/WO1993000915A1/en
Publication of RU93058535A publication Critical patent/RU93058535A/en
Application granted granted Critical
Publication of RU2108090C1 publication Critical patent/RU2108090C1/en

Links

Claims (1)

Настоящее изобретение обеспечивает новую композицию вещества и новый способ его приготовления. В частности, изобретение обеспечивает уникальные и новые 1000 мг - таблетки гидрохлорида колестипола, имеющие полезные свойства твердости и малой хрупкости и новый способ приготовления таких таблеток.The present invention provides a new composition of the substance and a new method for its preparation. In particular, the invention provides unique and new 1000 mg colestipol hydrochloride tablets having useful hardness and low brittleness properties and a new method for preparing such tablets.
RU93058535A 1991-07-03 1992-06-23 Tablet containing cholesterol hydrochloride and method for its production RU2108090C1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US72504491A 1991-07-03 1991-07-03
US07/725,044 1991-07-03
US07/725044 1991-07-03
PCT/US1992/005066 WO1993000915A1 (en) 1991-07-03 1992-06-23 Colestipol hydrochloride high-content tablets

Publications (2)

Publication Number Publication Date
RU93058535A true RU93058535A (en) 1996-09-20
RU2108090C1 RU2108090C1 (en) 1998-04-10

Family

ID=24912923

Family Applications (1)

Application Number Title Priority Date Filing Date
RU93058535A RU2108090C1 (en) 1991-07-03 1992-06-23 Tablet containing cholesterol hydrochloride and method for its production

Country Status (18)

Country Link
US (1) US5490987A (en)
EP (1) EP0592594B1 (en)
JP (1) JP3313710B2 (en)
KR (1) KR100240362B1 (en)
AT (1) ATE173931T1 (en)
AU (1) AU669664B2 (en)
CA (1) CA2110166C (en)
CZ (1) CZ286958B6 (en)
DE (1) DE69227773T2 (en)
DK (1) DK0592594T3 (en)
ES (1) ES2124736T3 (en)
FI (1) FI106843B (en)
HU (1) HU222242B1 (en)
NO (1) NO307686B1 (en)
PL (1) PL169045B1 (en)
RU (1) RU2108090C1 (en)
SK (1) SK281920B6 (en)
WO (1) WO1993000915A1 (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2129079C (en) * 1993-08-03 2006-01-17 Tatsuo Nomura Orally administrable cholesterol lowering agent
NZ503086A (en) * 1997-08-29 2002-03-01 Upjohn Co An orally administrable pharmaceutical composition comprising an inner core and two outer layers, which render it substantially free of unpleasant tastes
CN1202812C (en) * 1999-10-19 2005-05-25 基酶有限公司 Direct comperession polymer tablet core
US6733780B1 (en) 1999-10-19 2004-05-11 Genzyme Corporation Direct compression polymer tablet core
GB0123400D0 (en) 2001-09-28 2001-11-21 Novartis Ag Organic compounds
US20040109889A1 (en) * 2002-12-04 2004-06-10 Bunick Frank J. Surface treatment composition for soft substrates
EP1699442A2 (en) * 2003-12-31 2006-09-13 Genzyme Corporation Enteric coated aliphatic amine polymer bile acid sequestrants
US7985418B2 (en) 2004-11-01 2011-07-26 Genzyme Corporation Aliphatic amine polymer salts for tableting
CA2620406A1 (en) 2005-09-02 2007-03-08 Genzyme Corporation Method for removing phosphate and polymer used therefore
HUE026628T2 (en) 2005-09-15 2016-06-28 Genzyme Corp Sachet formulation for amine polymers
US7964182B2 (en) * 2006-09-01 2011-06-21 USV, Ltd Pharmaceutical compositions comprising phosphate-binding polymer
KR20090051240A (en) * 2006-09-01 2009-05-21 유에스브이 리미티드 Process for the preparation of sevelamer hydrochloride and formulation thereof
JP2010504975A (en) 2006-09-29 2010-02-18 ゲンズイメ コーポレーション Amide dendrimer composition
BRPI0720234A2 (en) 2006-12-14 2013-12-24 Genzyme Corp PHARMACEUTICAL COMPOSITION
WO2010041268A2 (en) * 2008-09-02 2010-04-15 Usv Limited Crosslinked polymers
KR20110119714A (en) * 2009-01-22 2011-11-02 유에스브이 리미티드 Pharmaceutical compositions comprising phosphate-binding polymer
US9763928B2 (en) * 2012-02-10 2017-09-19 Niconovum Usa, Inc. Multi-layer nicotine-containing pharmaceutical composition
MA41202A (en) 2014-12-18 2017-10-24 Genzyme Corp CROSS-LINKED POLYDIALLYMINE COPOLYMERS FOR THE TREATMENT OF TYPE 2 DIABETES

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3803237A (en) * 1969-11-03 1974-04-09 Upjohn Co Reaction products of polyethylenepolyamines and chlorohydrins or epoxy containing compounds
US3692895A (en) * 1970-09-08 1972-09-19 Norman A Nelson Method of reducing hypercholesteremia in humans employing a copolymer of polyethylenepolyamine and a bifunctional substance, such as epichlorohydria
ZA804914B (en) * 1979-08-29 1981-08-26 Rohm & Haas The production of powdered resin and the powdered resin so produced
US4439419A (en) * 1980-02-20 1984-03-27 The Upjohn Company Method of treating gastric hyperacidity in humans employing a copolymer of polyethylenepolyamine and a bifunctional substance as epichlorhydrin
US4404346A (en) * 1980-08-05 1983-09-13 Rohm And Haas Company Production of powdered resin and the powdered resin so produced
US4631305A (en) * 1985-03-22 1986-12-23 The Upjohn Company Polymeric material as a disintegrant in a compressed tablet
DE68907721T2 (en) * 1988-06-24 1993-11-18 Upjohn Co MILLED COLESTIPOL HYDROCHLORIDE.
IE63242B1 (en) * 1988-06-24 1995-04-05 Abbott Lab Pharmaceutical granules and tablets made therefrom
DE68911146T2 (en) * 1988-08-26 1994-04-14 Upjohn Co FINE-GRAINED COLESTIPOL HYDROCHLORIDE.

Similar Documents

Publication Publication Date Title
RU93058535A (en) TABLET CONTAINING KOLESTIPOL HYDROCHLORIDE AND METHOD FOR PRODUCING IT
HUT59306A (en) Process for producing pharmaceutical compositions comprising l-carnitine
HUP9800417A3 (en) 5-substituted-3-(1,2,3,6-tetrahydropyridin-4-yl)-indoles and 5-substituted-3-(piperidin-4-yl)-1h-indoles, their use as new 5-ht agonists, pharmaceutical compositions containing these compounds
CA2166483A1 (en) New Pharmaceutical Formulation
IL94404A0 (en) Oxadiazole and its salts,their preparation and pharmaceutical compositions containing them
IL91404A0 (en) Substituted 4-azatricyclo(22.3.1.0 4,9)octacos-18-ene derivations,their preparation and pharmaceutical compositions containing them
CA2193337A1 (en) 1-phenyl-2-dimethylaminomethyl-cyclohexan-1-ol compounds as pharmaceutical active ingredients
EE200000320A (en) Novel compounds
CA2348086A1 (en) Controlled-release pharmaceutical formulations
ZA965294B (en) Substituted 4-phenylaminothiazoles, their process of preparation and the pharmaceutical compositions containing them.
CA2110166A1 (en) Tableting of colestipol hydrochloride
CA2001572A1 (en) Compositions for treating tobacco withdrawal symptoms
HUT61554A (en) Process for producing 2,8-dioxabicyclo/3.2.1/octane derivatives and pharmaceutical compositions comprising same
DE69907926D1 (en) 1,2,4-TRIAZOL-3-THION COMPOUNDS
CA2220019A1 (en) Pharmaceutical composition containing tiagabine hydrochloride and the process for its preparation
CA2027814A1 (en) Treatment of hepatobiliary disease with 15-keto-prostaglandin compounds
ES8200678A1 (en) Dibenzazepine derivatives, their production and pharmaceutical compositions containing them.
IL95210A0 (en) 14,17alpha-etheno-and-ethanoestratrienes,process for the preparation thereof and pharmaceutical compositions containing the same
IT1230780B (en) PROCEDURE FOR THE PREPARATION OF 1,2 DICHLOR 1,1,2 TRIFLUOROETHANE.
CA2066532A1 (en) Pharmaceutical compositions
CA2002182A1 (en) Compositions for treating the premenstrual or late luteal phase syndrome and methods for their use
AU5194190A (en) Magnesium folates, process for their preparation and pharmaceutical compositions
FR2652590B1 (en) EXTRACELLULAR EXOPOLYMER, PROCESS FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME.
IL93759A0 (en) Platinum complexes,their preparation and pharmaceutical compositions which contain them
IL97321A0 (en) Diamine derivatives,their manufacture and pharmaceutical compositions containing them